Loading...
HSChapter 30
U.S. imports of hormone-containing medicaments (not in dosage form, no antibiotics) (HS 300339) totaled $18.0M in July 2026, traded with 12 countries.
Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics) imports of $18.0M in July 2026 ran 13% above the year-to-date monthly average of $15.9M.
Last updated: July 2026 dataBulk hormone-based pharmaceutical preparations — including artificial mixtures of natural hormones and other products of HS heading 2937 — enter the US under three distinct tariff lines (3003390000, 3003391000, 3003395000), allowing customs to differentiate synthetic, natural-mixture, and residual hormone formulations at the 10-digit level. Denmark and Belgium lead supply, with India, Italy, and Japan also significant sources, reflecting the global dispersion of active pharmaceutical ingredient (API) and intermediate manufacturing. Because these products are not yet in retail dosage form, they typically move through pharmaceutical supply chains as APIs or semi-finished goods destined for further domestic processing. FDA registration of the foreign establishment and compliance with cGMP standards are mandatory entry requirements.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
16 shipments/mo
The US schedule carves out artificial mixtures of natural hormones into their own 10-digit line (3003391000), separate from the broader catch-all for hormone medicaments (3003395000). The distinction turns on whether the active substance is a defined mixture of naturally occurring hormones versus a synthetic hormone or other product of heading 2937. Importers should confirm the precise chemical identity and mixture composition with their supplier to avoid misclassification.
Certain pharmaceutical intermediates and APIs from China may be subject to Section 301 tariffs depending on the specific product and tariff line. Importers sourcing from China should verify current Section 301 applicability for the relevant 10-digit HTS code before finalizing pricing. Consult a licensed customs broker for the current status of any applicable measures.
Subheading 2 of 10 in heading 3003
Subheading 300339 · $18.0M of $89.3M
ImportsExports
Imports
$18.0MYoY · Pro
Exports
$12.0MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Imports · July 2026
origin
Denmark and Belgium together supply 86% of it.
customs district
destination
entry
rate provision · imports
100.0% enters free of duty; the effective duty rate is 0.00%.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share |
|---|---|---|---|---|
| 3003395000 | Other Medicaments Containing Hormones Etc | $18.0M | 0.00% | 0.00% |
| 3003391000 | Artificial Mixtures of Natural Hormones | $0 | -- | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3003390000 | Medicament Cont Hormones or Prod of Hd 2937 Etc | $12.0M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
Supplier Network
Get discovered by U.S. importers searching for HS 300339 — Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics). Be the first supplier listed.